Bluejay Diagnostics (BJDX) Total Current Liabilities (2021 - 2023)
Bluejay Diagnostics' Total Current Liabilities history spans 3 years, with the latest figure at $1.8 million for Q4 2023.
- On a quarterly basis, Total Current Liabilities rose 7.99% to $1.8 million in Q4 2023 year-over-year; TTM through Dec 2023 was $1.8 million, a 7.99% increase, with the full-year FY2023 number at $1.8 million, up 7.99% from a year prior.
- Total Current Liabilities hit $1.8 million in Q4 2023 for Bluejay Diagnostics, down from $2.8 million in the prior quarter.
- Over the last five years, Total Current Liabilities for BJDX hit a ceiling of $2.8 million in Q3 2023 and a floor of $637162.0 in Q4 2021.
- Historically, Total Current Liabilities has averaged $1.5 million across 3 years, with a median of $1.5 million in 2022.
- Biggest five-year swings in Total Current Liabilities: skyrocketed 157.43% in 2022 and later grew 7.99% in 2023.
- Tracing BJDX's Total Current Liabilities over 3 years: stood at $637162.0 in 2021, then soared by 157.43% to $1.6 million in 2022, then increased by 7.99% to $1.8 million in 2023.
- Business Quant data shows Total Current Liabilities for BJDX at $1.8 million in Q4 2023, $2.8 million in Q3 2023, and $1.8 million in Q2 2023.